In health and social sciences, research questions often involve systematic assessment of the modification of treatment causal effect by patient characteristics. In longitudinal settings, time-varying or post-intervention effect modifiers are also of interest. In this work, we investigate the robust and efficient estimation of the Counterfactual-History-Adjusted Marginal Structural Model (van der Laan MJ, Petersen M. Statistical learning of origin-specific statically optimal individualized treatment rules. Int J Biostat. 2007;3), which models the conditional intervention-specific mean outcome given a counterfactual modifier history in an ideal experiment. We establish the semiparametric efficiency theory for these models, and present a substitution-based, semiparametric efficient and doubly robust estimator using the targeted maximum likelihood estimation methodology (TMLE, e.g. van der Laan MJ, Rubin DB. Targeted maximum likelihood learning. Int J Biostat. 2006;2, van der Laan MJ, Rose S. Targeted learning: causal inference for observational and experimental data, 1st ed. Springer Series in Statistics. Springer, 2011). To facilitate implementation in applications where the effect modifier is high dimensional, our third contribution is a projected influence function (and the corresponding projected TMLE estimator), which retains most of the robustness of its efficient peer and can be easily implemented in applications where the use of the efficient influence function becomes taxing. We compare the projected TMLE estimator with an Inverse Probability of Treatment Weighted estimator (e.g. Robins JM. Marginal structural models. In: Proceedings of the American Statistical Association. Section on Bayesian Statistical Science, 1-10. 1997a, Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11:561-570), and a non-targeted G-computation estimator (Robins JM. A new approach to causal inference in mortality studies with sustained exposure periodsapplication to control of the healthy worker survivor effect. Math Modell. 1986;7:1393-1512. The comparative performance of these estimators is assessed in a simulation study. The use of the projected TMLE estimator is illustrated in a secondary data analysis for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial where effect modifiers are subject to missing at random.
Introduction
In social and health sciences, research questions often involve systematic comparison of the effectiveness of different longitudinal exposures or treatment strategies on an outcome of interest. Specifically, consider a study where individuals are followed over time. In addition to their baseline covariates, we record their time-varying treatments, time-varying covariates, and the outcomes of interest. Time-varying confounding is ubiquitous in these settings: the treatment of interest depends on past covariates and in turn affects future covariates. Right censoring is often present, in response to past covariates and treatments. It has been widely recognized that in these cases, conventional analytic methods, such as multiple regressions, often fail to properly account for the time-varying confounding of the treatment effect (e.g. [7] ). Marginal Structural Models (MSMs), introduced by [4] , are well-established and widely used tools to address the problem of time-varying confounding. These models estimate the marginal expectation of an intervention-specific counterfactual outcome, i.e. the mean outcome of a subject in an ideal experiment where he/she was assigned to follow a given intervention.
To assess effect modification, MSMs are traditionally used to model the conditional counterfactual mean outcome given an observed history. Yet, in many settings one may wish to model the conditional counterfactual mean outcome given a counterfactual history. Consider the simple case of effect modification by base-line covariates. A traditional observed baseline MSM conditions on the observed baseline modifiers [7] and allows one to assess how the treatment effect changes as a function of the observed modifier values. (Observed) History-Adjusted MSMs (HA-MSMs), introduced in [8, 9] , generalize the observed baseline MSMs by modeling the counterfactual mean outcome given the observed history of treatment and modifiers of interest up till a time point.
However, since the modifiers of interest may be affected by their preceding treatment assignments, which may in turn depend on past modifiers and other covariates, the counterfactual mean within each stratrum of this history will also be affected by the observed treatment mechanism. In this case, the parameters of the HA-MSM would not be generalizable to an equivalent population with different or counterfactual treatment mechanisms [10] . We consider a model in which the true outcome that one wishes to model is the the conditional mean outcome given modifier history in an ideal experiment where subjects were assigned a given intervention of interest and a counterfactual history of the time-varying modifiers of interest.
To model these conditional counterfactual mean outcomes given a counterfactual history, we can use the so-called Counterfactual History Adjusted MSMs (CHA-MSM), introduced by [1] . Inverse Probability of Treatment Weighted (IPTW) estimators for CHA-MSM were proposed in [1] . These estimators are very intuitive, can be easily implemented using standard software, and offer influence function based standard error estimates. However, their consistency relies on consistent estimation of all the treatment weights. Doubly Robust IPTW (DR-IPTW) estimators for CHA-MSM were also described in [1] ; they were based on estimating equations derived by orthogonalizing the IPTW estimating function with respect to the treatment mechanism. These DR-IPTW estimators are consistent if the treatment weights or the conditional covariate and outcome densities are consistently estimated. Moreover, they are solutions to the estimating equation defined by the efficient influence function (EIF), and thus are asymptotically semi-parametric efficient.
Despite these advances, there are still many gaps in the efficiency theory and robust estimation of CHAMSMs. Firstly, even with the EIF being a key actor in semi-parametric estimation, there still lacks an explicit representation of it as an orthogonal decomposition of the nuisance parameters corresponding to the timevarying covariates. Compared to the IPTW-orthogonalized representation in [1] , such an explicit representation would provide a comprehensive picture of the efficiency theory for CHA-MSM. In particular, by shining a light on the role of the nuisance parameters in the EIF, such an explicit representation can inform the study of semi-parametric estimation for these models, advise on the trade-offs in estimating different nuisance parameters, and provide insights on the challenges and solutions to handling high-dimensional covariates. Secondly, estimating equation based estimators, e.g. the IPTW and the DR-IPTW, may be unstable in the presence of near positivity violations [11] , resulting in biased point and standard error estimates. In applications with dynamic treatment regimes, this instability is especially difficult to circumvent due to the limitations of effective weight stabilization. In contrast, a substitution-based estimator for these models can provide a way to maximize finite sample performance by preserving global information about the parameters. This paper aims to fill these gaps in the literature by establishing the efficiency theory for CHA-MSM and providing substitution-based, semi-parametric efficient and robust estimators. Firstly, we describe the identification of the conditional counterfactual intervention-specific mean outcome given a counterfactual history, and the identification of the corresponding MSM parameters of interest. Secondly, we determine the EIF for these statistical parameters as an orthogonal decomposition of the nuisance parameters. This EIF is used to construct a substitution-based, semi-parametric efficient and doubly robust estimator using the targeted maximum likelihood estimation methodology (TMLE, e.g. [2, 3] ). However, as we shall see, due to the form of the EIF, the computations in this estimator may prove arduous in applications where the effect modifiers are high dimensional. To address this problem, our third contribution is a projected influence function (and the corresponding TMLE estimator), which retains most of the robustness of its efficient peer and can be used in applications where the use of the EIF becomes taxing.
Illustrative example
Throughout this paper, we will illustrate our presentation using an example from mental health research. The STAR*D (Sequenced Treatment Alternatives to Relieve Depression) trial is a multi-level, longitudinal pragmatic trial of treatment strategies for major depression. After an initial screening, patients are enrolled into level 1 of the study, where everyone is assigned citalopram. At the start of each subsequent level, if a patient still remains in the study, then he/she is randomized to an option within one of the chosen treatment strategies. At level 2, the patient and his/her provider can choose between augmenting the citalopram with multiple options or switching to a new regimen with multiple options. We are interested in the comparative effect of augmenting vs switching medication. Because these two strategies are not randomized, this analysis is analogous to an observational study.
Suppose we wish to assess the effect modification of level 2 treatment strategy (augmenting vs switching) by the depression symptoms measured prior to entering level 2. Covariates either measured at enrollment or level 1 exit, for our purpose, are both considered baseline modifiers. These symptom measures are obtained at clinical visits and the level 1 exit survey. It is reasonable to believe that the more depressed patients and those less satisfied with their level 1 treatment may be less inclined to follow up with clinical visits or to respond to surveys. In this case, a simple complete-case analysis of effect modification may only provide results applicable to patients with less severe symptoms or more satisfied with their level 1 treatment. If we assume that this missingness, while associated with the outcome, can be predicted using covariate history collected up to level 1 exit, then we can regain some of the generalizability. Indeed, we cast these symptom measures as counterfactual variables under an intervention on their missingness mechanism. This way, the target parameter is formulated in terms of an ideal experiment where the report of the symptom measures was always ensured (i.e., intervened to be non-missing).
Organization of the article
This paper is organized as follows. In Section 2, we formulate the causal inference problem and determine the identifiability of the desired causal parameters from the observed data distribution. In Section 3, we present the EIF for the parameter of interest under a saturated semiparametric model, as well as a projected influence function. The robustness conditions for the efficient and projected influence functions are also established. We then present the construction of two TMLE estimators, one using the EIF (we call it the full TMLE) and one using the projected influence function (we call it the projected TMLE). For comparison we presented an IPTW estimator and a non-targeted substitution estimator. In Section 4, a simulation study demonstrates robustness properties of the projected TMLE. In Section 5, we use the STAR*D trial to illustrate the application of the projected TMLE. A final summary concludes the article.
Data structure and parameters of interest
For simplicity of exposition, we consider the case where one wishes to assess the conditional interventionspecific mean outcome given the counterfactual history up to the first time point.
Data structure
Specifically, consider a longitudinal data structure
where W encodes baseline covariates, A t encodes the exposures of interest and censoring indicators at time , encodes the time-varying history (between treatment 0 and 1 ) on which one wishes to condition, encodes covariates (including time-varying confounders and the outcome process ) measured between and +1 . Variable is the final outcome of interest. For the sake of discussion, assume that is either a binary or a bounded continuous variable (without losing generality, we may assume it is bounded in (0,1)). We note that in general, A t encodes intervention variables of interest, i.e. variables whose distribution one would set in an ideal experiment. These include exposure variables (where one would randomize in an ideal experiment) as well as censoring variables (where one would prevent in an ideal experiment).
For later convenience, we introduce some useful notations. For a time-varying variable , let X ≡ ( 1 , … , ) and X , ≡ ( , … , ) for < . We will also use the shorthand X = X . The equivalent notations in lower case will apply to the realizations of the corresponding variable. Finally, variables with degenerate indices, such as at = −1, are empty.
The time-ordering assumptions can be captured by a nonparametric structural equations model (NPSEM, [12] ):
This framework assumes that each variable in the observed data structure is an unknown deterministic function of all its preceding observed variables and some unmeasured exogenous random factors . We will refer to the observed variables in the input of as the parents of and denote their set as ( ).
Concretely, we describe the data example introduced in Section 1.1 with these notations. Our goal is to assess the effect modification of level 2 treatment strategy (augmenting vs switching) by the depression symptoms measured prior to entering level 2; yet many of these baseline effect modifiers were missing at random. By study protocol, all subjects will have either entered remission (treatment success), moved onto the next level (treatment failure), or dropped out (right censoring), by the end of 23 weeks of the level 2 period. For our study goal, the variables that we would enforce/randomize in an ideal experiment are the missingness status of the baseline effect modifier, the treatment assignment at the start of level 2, and the censoring status in each of the 23 weeks.
To this end, let be the baseline effect modifier of interest. Let 0 be the indicator for non-missingness of , and 1 be the treatment strategy received by a patient at level 2 ( 1 = 0 for augmenting medication and 1 = 1 for switching medication). We use W to encode the baseline covariates that may affect the measurement status 0 , and 0 to encode other baseline covariates (beside the modifier of interest) measured prior to treatment assignment 1 . Hence, under this indexing, = 24 and the first week of level 2 starts at = 2. For ≥ 2, A t is a counting process which drops to 0 if patient was censored by time , and are time-varying covariates such as visit statistics (duration in level thus far, visit frequency, etc), side-effect burden and symptom measures at time . The variable also contains two counting processes: the outcome process , which is a binary indicator for entering remission by time , and an exit process that jumps to 1 if a patient is moved to the next level, in which case the remission status will be zero for this level and the patient is considered non-censored (since the outcome was observed to be unsuccessful). Our final outcome of interest is -the remission status by the end of 23 weeks.
Parameter of interest
To assess the effect of the interventions, we study the intervention-specific counterfactual mean outcomes as a function of the interventions. These counterfactual mean outcomes can be obtained from an ideal experiment where one intervenes to assign A = a, and measures the resulting covariates and the outcome of interest. In our example, an ideal experiment would set 0 = 1 (always measure baseline modifier), 1 = 1 (switching or augmenting), and A 2, = 1 (always prevent drop outs). This data-generating process can be formalized using eq.
(1) by setting = in the equations for A t and in the parents of the non-intervention variables , and . We denote these resulting, possibly counterfactual, covariates as ( 0 ), (a ) and (a). Now, we wish to assess effect modification of such treatment effects by changing values of . That is, we ask "how does the differential effect of ( 0 , a * 1, ) vs ( 0 , a 1, ), and of ( 0 , a 1, ) vs ( 0 * , a 1, ), differ as a function of , which is affected by the treatment assignment A 0 ?". To answer this question, our parameters of interest are the so-called Counterfactual-History-Adjusted mean outcomes [ 
and our goal is to study how these mean outcomes change as a function of 0 , a 1, and . As discussed in Section 1, eq. (2) differs from the traditional History-Adjusted mean outcomes, ( ( 0 , a 1, ) | = , 0 = 0 ) , in that these traditional parameters condition on the observed treatment and modifier values. Hence within each such stratum, the conditional mean outcome may still depend on the observed treatment mechanism. As such, these parameters are affected by potential selection bias.
In our example, the conditional mean outcomes we wish to study are ( (1, a 1, ) | (1) = ), with {a 1, = ( 1 , … , ) ∶ 1 ∈ {0, 1}; = 1, ≥ 2}. In words, it is the intervention-specific counterfactual mean outcome in an ideal experiment without missing measurements or censoring.
A challenge to study of eq. (2) is that the curse of dimensionality arises in applications with more than two time points and/or with categorical or continuous . To address this issue, it is useful to summarize eq. (2) using a working MSM, (a, ), which is parametrized by a finite dimensional ∈ ⊂ ℝ . Since the outcome is binary (or bounded within the unit interval), concretely we consider a logistic MSM
where (a, ) is the vector of linear predictors in the generalized linear model. The methods presented here are easily modified to other forms of MSM.
Given a CHA-MSM eq. (3) for the conditional mean outcomes eq. (2), the true MSM parameter can be interpreted as the best summary measure of (a, ) as a function of a and . Formally, let denote the set of interventions of interest and denote the set of modifier values of interest. For a given kernel weight function ℎ(a, ), the true MSM parameter in eq. (3) is defined as
In words, yields the best weighted approximation of the counterfactual conditional dose-response curve (a, ), according to the quasi-loglikelihood loss, kernel weights and working model (a, ). The rest of this paper is devoted to the identification and inference of eq. (4) from the observed data.
Statistical estimand
To identify eq. (4) from the data generating distribution 0 , we make the Positivity Assumption (PA) and the Sequential Randomization Assumption (SRA, derived by [13] ). Specifically, under the PA, there exists > 0 such that
, for all and a ∈ , almost everywhere. The SRA assumes that
Under these conditions, the joint distribution ( ( 0 ), { (a) ∶ }) is identifiable from the observed data distribution 0 . In our STAR*D example, the plausibility of the SRA can be fortified by measuring sufficiently many confounders of the modifier's missingness, the treatment selection, and the censoring mechanism.
By calculations shown in the Appendix, the SRA allows us to identify ( ( 0 ) = ) as
and the counterfactual mean outcome (a, ) as
where, for = 0, … , ,
where l , −1 = ( , ..., −1 ) for t<j-1. Equation (7) represents a conditional expectation of the final outcome given observed histories (L −1 , , ) and under an intervention a on A.
For simplicity, we suppressed the notation for the functionals , , a , as each should be evaluated with respect to a given distribution. We will use ( ), ( ), a ( ) to express explicitly these functionals evaluated at a specific distribution when needed, but will keep the shorthand notation otherwise.
In comparison to eq. (6), parameters in conventional settings where the modifier is not counterfactual can be written as
The weight
adjusts for potential selection bias introduced by treatment assignment 0 = 0 . Indeed, if 0 does not depend on W (in our STAR*D example, this means missingness is completely at random), then this weight equals 1, in which case (a, ) is equivalent to the estimand in an analysis stratified by 0 .
Combining eqs. (5) and (6), the causal MSM parameter in eq. (4) identifies to
where the functionals , are evaluated at 0 . In the forthcoming sections, we study the statistical inference of Ψ( 0 ).
Notations
Before we proceed, let us introduce some more useful definitions and notations. Let ℳ be a saturated semiparametric model containing our data generating distribution 0 . The parameter of interest in eq. (8) is the map ↦ Ψ( ), from ℳ to ℝ , evaluated at 0 . Suppose we observe i.i.d. copies of ∼ 0 . Let denote the empirical distribution of this sample. For a function of , we will write ≡ 1 ∑ =1 , and for a distribution , we will write = ( ). Bang and Robins [14] noted the following recursive property when dealing with longitudinal interventionspecific mean outcomes:
for = 0, … , . This will prove useful in our upcoming endeavor. We also adopt the notations ( ) for the marginal distribution of , ( ) for the conditional distribution ( | , 0 ), and
We write for the treatment allocation probabilities
. When referring to a generic ∈ ℳ, we may sometimes write and in place of ( ) and ( ), similarly for their respective components. When referring to the functionals at the data-generating distribution 0 , we may sometimes write 0 and 0 , in place of ( 0 ) and ( 0 ). When there is no confusion, we will simply write and under the implied distribution.
Statistical inference: A tale of two influence functions
As defined in eq. (8), Ψ( ) optimizes a function of the functionals and evaluated at . Note also that (a, ) = , where
We will make use of the following useful characterizations for Ψ( ): (8), and and functionals evaluated at , we have
whereh (a, ) ≡ ℎ(a, ) (a, ), and the last expectation is taken over ( , 0 , ).
The derivations are straightforward, and we left them in the Appendix for reference.
Suppose that the following normalizing matrix is invertible at = Ψ:
Inverse probability weighted estimator
We note that these are functionals of ( ), but we have suppressed the notation here. From Remark 1, a valid estimating function for Ψ is given by
Up to a normalizing matrix ( ) −1 , ( , ) is a gradient for Ψ under a model ℳ where is known. Note that 0 ( ( 0 ), ) = ( 0 ) and the corresponding equation to zero is solved for 0 = Ψ( 0 ). Therefore, this is an unbiased estimating function for 0 and is an unbiased estimator if = ( 0 ). To implement the IPW estimator, we first obtain estimators of the probability of treatment propensityô f . For an observation in the dataset with A having a value in , the variable A () will have numerator equals 1 and probabilities in the denominator given bŷ
The estimator can be obtained by fitting a weighted logistic regression of on (A, ), with weights A ()h (A, ). This satisfies (, ) = 0, and it is consistent if̂consistently estimates . Under standard regularity and empirical process conditions, is asymptotically linear with influence function
. The asymptotic covariance of √ ( − 0 ) can be estimated by the sample covariance matrix Σ of { ( ) −1 (, )} . Due to its inverse weighting by products of treatment and censoring probabilities, this estimator may be sensitive to near positivity violations, wherein observations with small observed treatment propensity would be given excessive weight. This can be particularly pronounced as the number of time points increase. Substitution estimators like the ones we propose in sections 3.2 and 3.3 can slightly mitigate this problem by incorporating global information in the parameter map. However, the effect of near positivity violations can still take form of poor estimation in the nuisance parameters.
Non-targeted substitution estimators
and 0 0 0
From eq. (8) and Remark 1, we can formulate Ψ as Ψ ( a 0 , ) or Ψ ( a 0 , ) . These two formulations lead to two non-targeted substitution estimators, and 0 . Note the latter option opens the door for G-computation estimators in applications with high-dimensional .
We start by obtaining an estimator of a 0 ( , ) for a given a ∈ . We will exploit the recursive property of a noted in eq. (9), so that we can avoid estimation of densities, and will instead employ regression-based procedures to estimate the conditional expectations.
1. Initiate at = : We first regress on (L −1 , A, , ) among observations uncensored by time , to obtain an estimator of ( | L −1 , A, , ) . This can be implemented using data-adaptive (e.g. SuperLearner by [15] ) or parametric procedures. We then evaluate this fitted estimator at the observed (L −1 , , ) with setting A = a, to obtain an estimator̂a (L −1 , , ) for each observation uncensored at time − 1.
2. At each = − 1, … , 0, in decreasing order, we would have obtained an estimator̂a +1 (L , , ) for observations uncensored by time + 1. We now regress this variable on (L −1 , A , , ) among observations uncensored by time , and then evaluate the resulting fit at the observed (L −1 , , ) with setting A = a among observations uncensored at time − 1.
3. After running step 2 sequentially from = − 1 down to = 0, we would have an estimator̂a 0 ( , ) for each of the observations. We can now usêa 0 ( , ) to estimate Ψ through the characterizing equations in Remark 1.
Consider the first representation Ψ ( a 0 , ) . Let̂be an estimators of ( | 0 = 0 , ). For each a ∈ and each ∈ , we create a row of data consisting of̂a 0 ( , ), (a, ), ℎ(a, ),̂for each observation in the dataset. We then pool together these datasets characterized by (a, ). The estimator can be obtained by a weighted logistic regression of̂a 0 ( , ) onto (a, ) on the pooled dataset, with weights ℎ(a, )̂. This is consistent if botĥa 0 and̂are consistent. Here we use the empirical distribution to estimate the marginal distribution of .
Consider now the alternative representation Ψ ( a 0 , 0 ) , from the last equality in Remark 1. Let̂be an estimator of . For each a ∈ , we create a row of data consisting of̂a 0 ( , ), (a, ), ℎ(a, ) and ( 0 = 0 )/( 0 | ) for each observation in the dataset. We then pool together these datasets characterized by a. The estimator 0 can be obtained by a weighted logistic regression of̂a 0 ( , ) onto (a, ) on the pooled dataset, with weights ℎ(a, )
. This 0 is consistent if botĥa 0 and̂are consistent. Here we use the empirical distribution to estimate the marginal distribution of ( , 0 , ).
While these substitution estimators use weighted regressions to obtain estimators for 0 , they are less susceptible to extremely large weights than the IPW estimator described above. Indeed,̂is bounded within (0, 1) while the inverse 1/̂utilizes product of only one conditional probability. If the components are correctly specified parametric models, then the substitution estimators are also asymptotically linear and converge to a normal random variable at 1/2 . However, the parametric modeling assumptions are difficult to justify in scientific investigations. Data-adaptive alternatives may yield estimators which are not 1/2 consistent, which prohibits statistical inference.
Targeted maximum likelihood estimators
In a non-targeted substitution estimator, we can estimate the nuisance parameters of the data-generating distribution by stratification (nonparametric MLE), by fitting a parametric statistical model, or by using a machine learning algorithm. These estimates are then used to evaluate the parameter of interest. As the number of potential confounders increases, these methods may break down due to the curse of dimensionality, or yield a biasvariance trade off that is not optimal for the parameter of interest. The targeted learning approach aims at developing optimal ( 1/2 consistent, asymptotically normal, and efficient) estimators of smooth low-dimensional parameters through the use of data-adaptive machine learning [16] .
A targeted MLE adds a loss-based targeting step that aims to modify the initial estimators towards the parameter of interest, and provides potential robustness and semiparametric efficiency gains. The targeting is guided by an influence function for the target parameter eq. (8) . As a result of this targeting step, the final estimates of the nuisance parameters and of the target parameter satisfy a user-chosen score equation. Under certain regularity conditions, this yields inference based on the Central Limit Theorem. For example, it has been shown that both TMLE and the estimating equation based estimators (using the EIF as estimating equation) are double robust asymptotically efficient estimators under a Donsker class condition and a second order reminder condition [16] . The Donsker class condition roughly states that the EIF at and falls in a Donsker class such as multivariate real valued cadlag functions with uniformly bounded sectional variation norm. The second order condition states that the product, of (a) the 2 norm of the estimated outcome regressions minus their true counterpart with (b) the 2 norm of the estimated treatment/censoring mechanism minus their true counterpart, converges to zero at a a rate faster than 1/2 . The advantage of the TMLE is that it does not rely on the existence of a unique solution to the estimating equation. The TMLE estimators in this section are asymptotically linear and efficient under these conditions. They also allow different combination of rates for and . For example, if is known, then only consistency is needed for asymptotic efficiency. Another advantage of the targeted learning approach is that it does not rely on the existence of a unique solution of the estimating equation. Thus for marginal structural working models that are non-linear in parameters, the non-targeted estimating equations estimators may have multiple solutions or no solution. We refer to [2, 3] for the general methodology.
Efficient influence function
We first establish the EIF for our parameter of interest. From a fundamental result in [17] , under standard regularity conditions, the variance of the canonical gradient of Ψ provides a generalized Cramer-Rao lower bound for any regular and asymptotically linear estimators of Ψ. Therefore, this canonical gradient is a vital ingredient in building asymptotically linear and efficient estimators; fittingly, it is also commonly known as the EIF. For parameters in causal inference and missing data applications (such as those in our examples), the EIF also provides insights into the potential robustness against model mis-specifications.
From the first equality in Remark 1, we can obtain the EIF for Ψ via implicit differentiation. We formally state the result here and leave the proof in the Appendix.
Lemma 1 (Efficient Influence Function)
The EIF of Ψ at ∈ ℳ is given by ( ) −1 ( ), where
Proof
The proof is given in the Appendix.
Targeted MLE using the EIF ( ) ( ) ( )
The steps described in Section 3.2 can be used to obtain initial estimates of the components. The targeted estimators will sequentially update these initial estimates by finding a best fluctuation along a submodel given by components of ( ) in eq. (12) . Regarding a as a conditional expectation of a +1 , as given in eq. (9), we use the quasi loglikelihood loss function for a :
For a given ( , ), and each = 0, … , , consider the -dimensional working submodel { a ( ) ∶ }, with
This submodel satisfies ⟨ ∑ a ( a ( )) | =0 ⟩ ⊃ ⟨ ( , )⟩, where ⟨ ⟩ represents the linear span of a vector .
Next, we rewrite and in eq. (12) as
We also consider the loss function ( ) ≡ − log , and a -dimensional fluctuation model through a given at = 0 given by
where ( , ) ≡ ∑ a
It is easy to verify that ⟨ ( ( ))| =0 ⟩ ⊃ ⟨ ( , , )⟩. This can be implemented by creating one row for each individual and each a ∈ , and fitting a weighted logistic regression of on the multivariate covariate (a, ) a () on these observations with weights ℎ(a, ) and offset̂a (L −1 , , ). Update the initial estimator usinĝ * ,a ≡̂a (̂).
2. At each subsequent step = − 1, … , 0, we have thus far obtained an updated estimator̂ * ,a +1 for each a ∈ . Regresŝ * ,a +1 on (L −1 , A , 0 , , ) and evaluate at A = a to get an initial estimator̂a of a . The optimal fluctuation amount around this initial estimator is given bŷ= arg min ∑ a (̂a( )) , and can be obtained in an analogous manner to step 1. The updated estimator iŝ * ,a ≡̂a(̂).
3. After sequentially performing step (2) in decreasing order of , we now have a targeted estimator̂ * 5. Given 1 obtained in previous step, we update the estimator for as follows. Using previously obtained̂ * ,a 0 ,, and 1 , the optimal fluctuation amount around the initial̂is given bŷ= arg min
. This can be obtained by solving for in the equation
0 ∶ a), 1 ) . The updated density is given bŷ1 , ≡̂( ).
6. Having obtained a parameter estimate and an updated densitŷ, at the -th iteration, repeat step (4) and (5) to obtain a targeted estimate +1 and̂+ 1, , until̂converges to 0. In practice, this convergence can be achieved (close to 0) after a few iterations. We denote the final updates as * , and̂ * , . We call this estimator, * , , the full TMLE.
Let̂ * ≡ (̂,̂ * , ,̂ * ,a ) , wherêis the empirical distribution of . By design, * (̂ * ,, * , ) = 0. From Lemma 1, we know that * , is consistent if either̂ * = 0 or̂= 0 . Under standard regularity and empirical process conditions, * , is asymptotically linear with influence function (Ψ) −1 * (Ψ). The asymptotic covariance of √ ( * , − 0 ) can be estimated by the sample covariance matrix Σ * , of { ( * , ) −1 * (̂ * ,, * , )} . In particular, since (Ψ) −1 * (Ψ) is the canonical gradient of Ψ, the estimator * , is asymptotically efficient if all relevant components in * are consistently estimated.
Remark 2
To 
Projected influence function

Lemma 2 (Projected Influence Function) Consider the setup in Lemma 1. The influence function for Ψ at under the model
In particular, it is a valid estimating function for Ψ ∶ ℳ → ℝ .
Proof
At its face value, the proposed 0 may seem less robust than the EIF , as it always relies on consistent estimation of ( 0 | ). However, as we noted in Remark 2, when is high-dimensional, there are more standard machine learning algorithms available for estimating ( 0 | ), which is the propensity score of a binary treatment. Moreover, as it becomes apparent in the next section, the estimators that utilizes 0 , which we call the projected TMLE, are also easier to implement, since standard software packages can be used, and no iterated updates are required in the targeted estimator.
Targeted TMLE using the PIF
We follow steps (1) and (2) in Section 3.3.2. We use the loss functions eq. (13) and fluctuation models eq. (14) to estimate and updatê * ,a , sequentially from = to = 1.
We now have a targeted estimator̂ *
,a
1 . We obtain an estimator , i.e., the projected TMLE of 0 by fitting a weighted logistic regression of̂ * ,a 1 ( 0 , , ) on (a, ), with weights ℎ(a, )
By construction, 0 (̂ * ,a ,, ) = 0. From Lemma 2, is a consistent estimator of 0 if( 0 | ) is consistent, and either̂ * ,a or( | A −1 , L −1 , , ), for = 1, … , are consistent. Compared with the full TMLE using ( ) in the previous section, this estimator is particularly appealing when is high-dimensional, and still provides more robustness protection than the IPTW or the non-targeted substitution estimators. Moreover, under standard regularity and empirical process conditions, is asymptotically linear with influence function (Ψ) −1 0 . The asymptotic covariance of √ ( − 0 ) can be estimated by the sample covariance matrix Σ of ( ) −1 0 (̂ * ,a ,, ) .
Simulation study
In this section, we examine the relative performance of the IPTW estimator (Section 3.1), the G-computation (i.e., non-targeted substitution) estimator (Section 3.2), and the projected TMLE estimator (Section 3.3.4) for the parameters of an MSM model. Though the full TMLE is the most efficient, as Remark 2 noted, when is high dimensional, correct specification of all conditional densities of given 0 , may be difficult. The simulation is thus focused on the performance of the projected TMLE in comparison with the IPTW and G-computation estimators.
Data generating process and target parameter
We consider an example with data structure = ( , 0 , , 0 , ( , ) ∶ = 1, … ) with = 3, where 0 is the missing mechanism for , 1 is the treatment assignment, and A t for > 1 is the indicator of remaining in the study by time . Time varying covariate consist of 1 , 2 , and the death indicator . The data generating process is as follows:
Once either the censoring equals to 0 or death process equals to 1, then all subsequent variables are encoded by carrying forward their last observation.
Our interventions of interest are = {(1, 0, 1, 1), (1, 1, 1, 1)}. Under the above distribution, 0.1 < ( 1 = 1 | ⋅) < 0.95, and ( = 1 | ⋅) > 0.5 for all ≥ 2.
We model the dose response { (a, ) ∶ a, } by the MSM
where (a, ) = (1, 1 , 1 , 2 , 1 1 , 1 2 ) , with kernel weights ℎ(a, ) = ( 1 | , 0 = 0 ). Note that in this case, the kernel weights are assumed to be known. The target parameter defined in eq. (8) 
Estimators
The propensity scores ( 0 | ) is estimated using Super Learner [15] , with base algorithms glm and nnet, adjusting for 1 and 2 . This is considered a correct specification of the propensity for 0 . We use two estimators for the subsequent propensities at ≥ 1: a correctly specified logistic model (shorthand 'gc'), and a misspecified logistic model ('gm') that misses some key baseline and time-varying covariates. The denominator for each a ( ) is truncated below by 0.025. We use two estimators for a : the correctly specified estimator ('Qc'), and the misspecified estimator ('Qm') only adjusts for 1 and 2 at each time . Both estimators Super Learner with candidate fitting algorithms glm and nnet.
We consider three cases of model misspecification on a and ( | ⋅) for ≥ 1: all correct ('Qc, gc'); correct a and misspecified ('Qc,gm'); misspecified a and correct ('Qm, gc'). For all three cases we always use the same correctly specified ( 0 | ). We implement the second version of the G-computation estimator in Section 3.2, where the weights are given by . This estimator changes only under specifications 'Qc, gc' and 'Qm, gc'. The IPTW estimator changes only under specifications 'Qc, gc' and 'Qc, gm'.
Results
The bias, variance, and coverage probability (for the influence function-based confidence intervals) are appraised using 500 and 2000 repetitions.
In Table 1 , we see that when is misspecified, projected TMLE using a correct a reduces bias over the misspecified IPTW estimator. Similarly, when a is misspecified, projected TMLE using the correct reduces bias over the misspecified G-computation estimator. When comparing the correct vs misspecified G-computation estimators, and the correct vs misspecified IPTW, coefficients involving the adjusted covariates ( 1 , 2 ) were still estimated very well by the misspecified estimator. Under 'Qc, gc', the correct G-computation estimator converges much slower than the IPTW and the projected TMLE estimators. We posit that this may be due to its sole reliance on the nonparametric likelihood estimates. As expected, G-computation has the smallest sample variance, and IPTW has the largest sample variance despite the truncated estimators for .
Under certain regularity conditions, the IPTW and projected TMLE estimators are asymptotically linear. Table 2 tabulates the coverage probability of their influence function based confidence intervals. At the correct models 'Qc,gc', IPTW and projected TMLE are asymptotically linear with influence function and 0 , respectively. We used √̂/ and √̂0 / to estimate their respective standard errors. As sample size grows, the actual coverage probability is quite close to the nominal coverage probability, with IPTW having a better coverage. When one of the components is misspecified, the projected TMLE still provides very good coverage, even though theoretically 0 is only part of its influence curve; we postulate that this is because the influence function based standard error estimates are large relative to the finite sample bias. The misspecified IPTW has very good coverage for the covariates that were adjusted for in the misspecified model, but very bad coverage for the confounded coefficients ( and the intercept). 
Data analysis example
To illustrate the application of the projected TMLE, we revisit our STAR*D example. After an initial screening, patients are enrolled into level 1 of the treatment, where everyone is treated with citalopram. At the start of each subsequent level, if a patient still remains in the study, then he/she is randomized to an option (i.e. a particular medication) within one of his/her accepted treatment strategies (augmenting vs switching). Regular follow-up visits are conducted throughout each level. At each follow-up visit, covariates are collected, and the patient is subject to dropout, entering remission, or moving onto next level if treatments fail. In the field of depression research, there is very little consistent literature concerning individual baseline characteristics that may differentially modify the effect of switching medication vs augmenting medication on remission. Because the strategies themselves are not randomized, this analysis is de facto equivalent to that of an observational study. Our estimators will account for baseline and time-varying confounding. All candidate modifiers are a priori selected through a literature review of previous START*D publications. These covariates are measured prior to the assignment of level 2 treatment, either at study screening, clinical visits or exit surveys at the end of level 1. Many of these candidate modifiers are subject to missingness, often times due to missing visits and surveys, therein lies the need for the tools developed here. Our study population is the set of 1395 patients at level 2 who found medication strategies acceptable. Table 3 tabulates the events in level 2 by strategies received. Note that there are three strategies, but we are only comparing switching medication vs augmenting medication. The data structure was described in detail in Section 2 as part of our running example.
We consider here two types of potential effect modifiers: some are measured at enrollment and some are measured at exit of level 1. If is a baseline covariate, W includes all demographic variables and medical and psychiatric history prior to enrollment; if is a level 1 exit covariate, then we add to W variables summarizing number of visits, adherence to study protocol, and time spent in level 1. Table 4 summarizes percent of missingness, range, and scale of each effect modifier. Of all the candidate modifiers proposed by literature review, we exclude from our analysis the history of amphetamine use at baseline and history of drug abuse, since these two variables are missing for more than 70% of the patients. The multivariate nature of most of the effect modifiers underscores the need for projected TMLE. The analysis below compares medication switching (Sw) and medication augmentation (Aug) only. for the semi-continuous . The kernel weights are ℎ(a, ) = ( 1 = 1 | ), to be estimated using Super Learner with fitting algorithms glm, knnreg, nnet and bayesglm. The Super Learner will use 10-fold cross validation to select the best weighted combination of these fitting algorithms to estimate ℎ(a, ). The initial estimators of and a adjust for all baseline covariates and time-varying covariates with up to 2 time lag (each covariate is coupled with its missingness indicator). Each fitting algorithm is coupled with each of the following screening algorithms: Spearman correlation tests at significance levels 0.01, 0.05, 0.1, 0.2; ranking p-values from the correlation tests and take the top variables, where ranges from 10 variables up to 30% of the total number of variables being considered, in increments of 20. The Super Learner selects the best linear combination of all screening-fitting couples.
The goal of the analysis is to identify potential effect modifiers from a pool of candidate pre-treatment covariates. Our strategy is to measure the treatment heterogeneity for each of these covariates using an MSM, and then apply multiple testing methods to identify those for which the treatment heterogeneity is significant. A common way to assess treatment heterogeneity across strata of is to test whether the coefficients of the interaction terms 4 are different from 0. We perform the corresponding Wald test in Table 5 , with the null hypothesis 4 = 0 and test statistics = 4, ⊤ Σ −1 4, ∼ 2 , where 4, is the projected TMLE estimator,
)/ , and is the number of interaction terms. The false discovery rate (FDR) of the simultaneous comparisons is controlled at 0.05 with the Benjamini-Hochberg procedure. 
where is given by projected TMLE, and Σ is the corresponding covariance estimator based on the covariance matrix of the projected-IF. Control false discovery rate at 0.05 with the Benjamini-Hochberg procedure. Since these candidate covariates differ in their type (semi-continuous vs binary vs multiple categories), the corresponding MSM parameters are of different dimensions, we also consider the measure of treatment heterogeneity This measure quantifies the most change in log odds ratio between any two values of . Consider the null hypothesis 0 ∶ ( 0 ) = 0. Using projected TMLE, we obtain an estimator = ( ) for each . An application of the functional delta method, with the covariance matrix Σ of the estimated influence function 0 , yields a standard error estimate for . We use the test statistics = / ∼ (0, 1). The results of the analysis are summarized in Table 6 . Interestingly, this approach yields almost all the same potential effect modifiers as in Table 5 .
P-value Reject
Using our methods, we identified six factors, two at screening and four at level 1 exit, that modified the comparative treatment effect of augmenting vs switching medication. These effect modifiers are: prior suicide attempts, atypical depression, level 1 side-effect frequencies and burden (impairment), SF-36 physical functionality, and quality of life at level 1 exit. In general, the heterogeneity of the treatment effects are most pronounced for the level 1 exit modifiers than for those from baseline, indicating opportunities for close monitoring and medication management.
There has only been one publication that addressed the heterogeneous treatment effects between switching and augmenting in level 2 treatment in STAR*D [18] . The authors employed propensity score and weighting methods to examine heterogeneity of the treatment effect among the treated (medication augmentation) through stratification by propensity score decile. This approach does not explicitly identify factors contributing to heterogeneity. Missing data is less problematic in this case, and is handled by multiple imputation.
Summary
In this work, we studied causal effect modification by a counterfactual modifier. The tools developed here are applicable in situations where the effect modifier of interest may be better cast as counterfactual variables. Examples of such situations include the study of time-varying effect modification, or the study of baseline effect modification with modifiers that are missing at random.
We established the efficient influence function (EIF) for the corresponding marginal structural model parameters which provides the semiparametric efficiency bound for all asymptotically linear estimators. This EIF is also doubly robust in that it remains an unbiased estimating function if either 1) the outcome expectations and the modifier densities, or 2) the treatment and censoring mechanisms, are consistently estimated. However, in applications with high-dimensional effect modifiers, we saw that it may be difficult to fully utilize the EIF without potentially compromising consistency. To solve this problem, we presented a projected influence function (PIF), which equals the EIF in a model where the missingness mechanism (or more generally, pre-modifier intervention, 0 ) is known. Though not fully efficient under the larger model, this PIF is robust against misspecification of the outcome models or the treatment mechanisms, whenever the missingness mechanism is consistently estimated. We presented two TMLE estimators using the EIF and the PIF. We also described an IPTW estimator that is unbiased if the intervention probabilities are consistently estimated, and a non-targeted G-computation estimator that is unbiased if the outcome expectations and either the modifier densities or the missingness mechanisms are consistently estimated. Under standard regularity and empirical process conditions, the two TMLE estimators and the IPTW estimators are asymptotically linear, thereby allowing Central Limit Theorem based standard error estimates. Moreover, the full TMLE estimator using the EIF will be semiparametric efficient if all the components of the likelihood are consistently estimated. 
B Proof of Remark 1
The first equality in the remark follows from definition of Ψ( ) and choice of (a, ), the third equality is trivial. We only show the second one. 
Next, for a given (a, ), we proceed to express 1 + ( | a, ) .
Proposition 1
For a given ( 0 , ), In obtaining the last equality, we note that centering the left factor of the integrand by ( )( 0 , ) does not change the expression because ( ( ) ( )) = ( ) ( ( )) = 0 by definition of . It is straightforward to check that indeed ( ) = 0. Moreover, under our saturated model ( ) is in fact in the tangent space. This concludes the proof of Proposition 1.
Proposition 2
For a given a ∈ , ∈ , ( In the first equality, and ′ are shorthand for the remaining terms in the expansion of the products. This concludes the proof of Proposition 2 Now, we derive the EIF for Ψ at ∈ ℳ. From Proposition 1 and Proposition 2, after some simplifications, we conclude that the right-hand-side of eq. (17) 
